Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Total Debt: 2020-2024

Historic Total Debt for Mainz Biomed N.V (MYNZ) over the last 1 years, with Dec 2024 value amounting to $1.0 million.

  • Mainz Biomed N.V's Total Debt fell 78.99% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 78.99%. This contributed to the annual value of $1.0 million for FY2024, which is 78.99% down from last year.
  • As of Q4 2024, Mainz Biomed N.V's Total Debt stood at $1.0 million, which was down 78.99% from $4.9 million recorded in Q4 2023.
  • Over the past 5 years, Mainz Biomed N.V's Total Debt peaked at $7.5 million during Q2 2023, and registered a low of $24,527 during Q4 2020.
  • In the last 3 years, Mainz Biomed N.V's Total Debt had a median value of $4.9 million in 2023 and averaged $4.2 million.
  • Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 5,411.29% in 2021, then tumbled by 78.99% in 2024.
  • Over the past 5 years, Mainz Biomed N.V's Total Debt (Quarterly) stood at $24,527 in 2020, then soared by 5,411.29% to $1.4 million in 2021, then fell by 27.84% to $975,395 in 2022, then soared by 398.16% to $4.9 million in 2023, then tumbled by 78.99% to $1.0 million in 2024.
  • Its Total Debt was $1.0 million in Q4 2024, compared to $4.9 million in Q4 2023 and $6.9 million in Q3 2023.